MAPT and neuroblastoma: Here, overexpression of GSK3β in SH-SY5Y neuroblastoma cells increased not only the levels of tau phosphorylation (Figure 2A,B), but also enhanced the cellular immunoreactivity to the tau oligomeric antibodies T22 (Figure 2A–C).